Back to Search
Start Over
Real-world data on the comparison of LDL-C lowering effects between alirocumab and evolocumab.
- Source :
-
Atherosclerosis (00219150) . Aug2022, Vol. 355, pN.PAG-N.PAG. 1p. - Publication Year :
- 2022
- Subjects :
- *LDL cholesterol
Subjects
Details
- Language :
- English
- ISSN :
- 00219150
- Volume :
- 355
- Database :
- Academic Search Index
- Journal :
- Atherosclerosis (00219150)
- Publication Type :
- Academic Journal
- Accession number :
- 158778855
- Full Text :
- https://doi.org/10.1016/j.atherosclerosis.2022.06.858